For example, investigators use HTCP to investigate interactions between gene deletion mutations and additional chemical or genetic perturbations by assessing differences in cell proliferation among the collection of 5000 S. cerevisiae gene deletion strains.
In the San Bernardino case, for example, the investigators obtained records from Farook's employer's cellular provider, which would have included details of all of the calls he placed on the device, and perhaps his saved messages.
In one case, for example, the investigators say Daimler transferred thousands of euros directly into the personal bank account of an official in charge of vehicle procurement in a provincial city.
In studies of moderate exercise to help prevent diabetes, for example, investigators had to go to great lengths just to keep subjects in a walking program.
For example, some investigators analyzed data for liver cancer deaths with the board category of digestive system cancer deaths, while others combined data for CNS cancer deaths with the broad category of "other and unspecified cancer," and most studies analyzed information for lymphatic and hematopoietic system cancer deaths with all data combined.
In Connecticut, for example, investigators have no idea why five bodies were piled for years in the garage at Wade Funeral Home, which operated without a license for a year.
For example, investigators often sequence samples of unrelated affected and unaffected individuals for comparison.
For example, investigators will need to consider when the additional subject interactions become overly burdensome on particular populations for example, minority communities that may have been studied extensively in the past.
For example, investigators could be encouraged to incorporate standardized alcohol consumption questions, particularly for patterns of consumption, and to obtain DNA samples using proper consent for genetic studies, where appropriate.
For example, investigators have been interested in finding actionable mutations that can be used for development of precision medicine strategies from thousands of mutations or even more in an individual genome.
